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ABSTRACT The opportunistic fungal pathogen Scedosporium boydii is the most com-
mon Scedosporium species in French patients with cystic fibrosis. Here we present the
first genome report for S. boydii, providing a resource which may enable the elucidation
of the pathogenic mechanisms in this species.
The filamentous fungus Scedosporium boydii (formerly Pseudallescheria boydii) is asoil saprotroph. As an opportunistic pathogen, it causes infections in humans
ranging from localized infections, such as subcutaneous mycetoma (1), to fatal dissem-
inated infections in immunocompromised patients, particularly after lung or heart-lung
transplantation (2). Scedosporium boydii has received increasing attention since it was
recognized as a significant pathogen for patients with cystic fibrosis (CF) (3). Scedospo-
rium boydii was long considered the sexual state of Scedosporium apiospermum, but a
multifaceted study has demonstrated that S. boydii and S. apiospermum are distinct
species, and a new species, Scedosporium dehoogii, was therefore proposed (4). Since
then, several new species have been assigned to the Scedosporium genus, which now
comprises 10 species (A. Ramirez-Garcia, A. Pellon, A. Rementeria, I. Buldain, E. Barreto-
Berguer, R. Rollin-Pinheiro, J. V. de Meirelles, S. Ranque, V. Havlicek, P. Vandeputte, Y. Le
Govic, J.-P. Bouchara, S. Giraud, S. Chen, J. Rainer, A. Alastruey-Izquierdo, M. T. Martin-
Gomez, L. M. López-Soria, J. Peman, C. Schwarz, A. Bernhardt, K. Tintelnot, J. Capilla,
A. M. Vicente, J. Cano-Lira, M. Nagl, M. Lackner, L. Irinyi, W. Meyer, S. de Hoog, F. L.
Hernando, submitted for publication). The most frequent species associated with CF
differ between countries: Scedosporium apiospermum is particularly common in CF in
Germany (5), and Scedosporium aurantiacum in Australia (6), representing 55% and 50%
of all Scedosporium isolates, respectively, while S. boydii is the predominant species in
French CF patients (62% of the isolates) (7). Genomes of S. apiospermum and S. auran-
tiacum species have been published recently (8, 9), and here we report the genome of
Scedosporium boydii IHEM 23826, isolated on 26 November 2009 at the University
Hospital of Angers from respiratory secretions of a CF patient. This is the first genome
report for this species.
Genomic DNA was sequenced on an Illumina MiSeq platform, generating a total of
2.25 million paired-end reads of 300 bp in length at the ANAN technical platform of the
SFR Quasav (INRA, Université d’Angers). We used Trimmomatic (version 0.36) (10) to
clean the reads before genome assembly with the SPAdes pipeline (version 3.9.0) (11).
The genome assembly was 43.3 Mb in length, consisting of 587 contigs ranging from
0.5 to 520 kb in size. Using the BUSCO pipeline (version 1.1b1) (12), we estimated the
completeness of our genome to be 98.7% (1,419 ultraconserved genes found out of
1,438), which is very similar to the 98.82% (1,421 genes found) of the genome of
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S. apiospermum strain IHEM 14462 (8). The GC content and N50 value were 50.69% and
151,073 bp, respectively.
Gene prediction was performed using Augustus (version 3.2.3) (13). Training files
used for the gene prediction were produced with the BRAKER1 program (14) for the
closely related fungus S. apiospermum (strain IHEM 14462), using RNA sequencing data
from a number of different growth conditions (our unpublished results). Using this
approach, 11,633 genes were predicted in the S. boydii genome. This is comparable to
S. apiospermum strain IHEM 14462 and S. aurantiacum strain WM09.24, with 10,919 and
10,525 predicted genes, respectively (8, 9).
These additional genomic resources will allow comparative genomic analysis to be
made among pathogenic Scedosporium species and will increase the data available to
study the molecular basis of pathogenicity and antifungal drug resistance in these
organisms.
Accession number(s). This whole-genome shotgun project has been deposited at
DDBJ/EMBL/GenBank under the accession number NJFT00000000. The version de-
scribed in this paper is the first version, NJFT01000000.
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